UnitedHealth Group Incorporated (NYSE:UNH) Stake Lowered by Shorepoint Capital Partners LLC

Shorepoint Capital Partners LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 37.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,633 shares of the healthcare conglomerate's stock after selling 3,312 shares during the period. Shorepoint Capital Partners LLC's holdings in UnitedHealth Group were worth $2,850,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in UNH. Sugarloaf Wealth Management LLC raised its holdings in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after acquiring an additional 1,193 shares during the period. Signal Advisors Wealth LLC raised its stake in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after purchasing an additional 1,051 shares during the last quarter. Waycross Partners LLC raised its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after buying an additional 658 shares during the last quarter. Czech National Bank increased its stake in UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock valued at $100,937,000 after acquiring an additional 11,426 shares during the period. Finally, Lmcg Investments LLC increased its position in shares of UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock valued at $19,210,000 after purchasing an additional 4,022 shares during the period. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Mizuho boosted their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a report on Thursday. Finally, Oppenheimer reduced their price objective on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research note on Monday, April 21st. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Buy" and a consensus target price of $603.05.

UnitedHealth Group Trading Down 1.4 %

UNH opened at $418.20 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $380.66 billion, a P/E ratio of 26.98, a P/E/G ratio of 1.37 and a beta of 0.61. The firm's fifty day simple moving average is $503.28 and its 200 day simple moving average is $534.62. UnitedHealth Group Incorporated has a 12 month low of $412.02 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the firm earned $6.91 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.